Raj Som Pruthi - 22 Jul 2024 Form 3 Insider Report for enGene Holdings Inc. (ENGN)

Role
Chief Medical Officer
Signature
/s/ Lee Giguere, as attorney-in-fact for the Reporting Person
Issuer symbol
ENGN
Transactions as of
22 Jul 2024
Net transactions value
$0
Form type
3
Filing time
25 Jul 2024, 20:30:09 UTC
Next filing
25 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ENGN Stock Option (Right to Buy) 22 Jul 2024 Common Shares 125,000 $14.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests at 25% on April 8, 2025, which is the first anniversary of Dr. Pruthi's employment commencement date, with the remaining portion to vest monthly over the remaining three years.

Remarks:

Exhibit 24 - Power of Attorney